Sonendo, Inc. (SONX)
- Previous Close
0.0853 - Open
0.0903 - Bid --
- Ask --
- Day's Range
0.0865 - 0.0927 - 52 Week Range
0.0450 - 1.4700 - Volume
24,920 - Avg. Volume
438,289 - Market Cap (intraday)
6.13M - Beta (5Y Monthly) 1.62
- PE Ratio (TTM)
-- - EPS (TTM)
-0.6200 - Earnings Date Aug 7, 2024 - Aug 12, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
0.25
Sonendo, Inc., a commercial-stage medical technology company, develops, manufactures, and commercializes devices for root canal therapy in the United States and Canada. It provides GentleWave, a tooth decay treatment, a technology platform designed for cleaning and disinfecting the microscopic spaces within teeth without the need to remove tooth structure. The company also offers SoundSeal, a material used to build and create a sealing platform on the top of the crown; and Sonendo-branded liquid solution of ethylenediaminetetraacetic acid EDTA that is used to help debride and disinfect the root canal system. In addition, it provides The Digital Office, a practice management software to enable an integrated digital office for dental practitioners. The company was formerly known as Dentatek Corporation and changed its name to Sonendo, Inc. in March 2011. The company was incorporated in 2006 and is headquartered in Laguna Hills, California.
sonendo.comRecent News: SONX
Performance Overview: SONX
Trailing total returns as of 5/28/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: SONX
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: SONX
Valuation Measures
Market Cap
6.13M
Enterprise Value
-2.69M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.19
Price/Book (mrq)
0.24
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
-123.86%
Return on Assets (ttm)
-33.97%
Return on Equity (ttm)
-123.43%
Revenue (ttm)
42.23M
Net Income Avi to Common (ttm)
-57.47M
Diluted EPS (ttm)
-0.6200
Balance Sheet and Cash Flow
Total Cash (mrq)
33.59M
Total Debt/Equity (mrq)
100.98%
Levered Free Cash Flow (ttm)
-16.88M